Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianjun Han

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|November 28, 2012
Leukocyte telomere length-related genetic variants in 1p34.2 and 14q21 loci contribute to the risk of esophageal squamous cell carcinomaJuan Shi, Fang Sun, Li Peng, et al.
American Journal of Cancer Research|November 14, 2019
Reversal of obesity-driven aggressiveness of endometrial cancer by metforminHui Guo, Weimin Kong, Lu Zhang, et al.
Eclinicalmedicine|January 30, 2023
A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study)Yuanyuan Zhao, Yunpeng Yang, Fangfang Gao, et al.
Radiology. Imaging Cancer|September 5, 2025
Using Machine Learning to Predict Advanced-Stage Progression of Intermediate-Stage Hepatocellular Carcinoma after Transarterial ChemoembolizationRan Wei, Zelong Liu, Lingjie Ju, et al.
Journal of Hematology & Oncology|September 23, 2016
NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivoLu Zhang, Jianjun Han, Amanda L Jackson, et al.
Breast Cancer Research : BCR|February 13, 2025
Clinical efficacy and therapy response prediction of neoadjuvant dalpiciclib plus letrozole in postmenopausal patients with HR+/HER2- stage II-III breast cancer (DARLING 01): a single-arm, open-label, exploratory studyLina Zhang, Yueping Liu, Chao Yang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 13, 2018
[Expert Consensus for Image-guided Radiofrequency Ablation of Pulmonary Tumors (2018 Version)]Baodong Liu, Xin Ye, Weijun Fan, et al.
Oncotarget|October 4, 2017
Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancerLi Sun, Yajie Yin, Leslie H Clark, et al.
Pancreas|August 4, 2021
Transcatheter Arterial Infusion Combined With Radioactive Particles in the Treatment of Advanced Body/Tail Pancreatic Cancer: A Retrospective Cohort StudyShilong Han, Chuanwu Cao, Yifeng Yuan, et al.
Frontiers in Oncology|July 19, 2021
Consensus of Minimally Invasive and Multidisciplinary Comprehensive Treatment for Hepatocellular Carcinoma - 2020 Guangzhou RecommendationsQi-Feng Chen, Wang Li, Simon Chun-Ho Yu, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|November 28, 2012
Leukocyte telomere length-related genetic variants in 1p34.2 and 14q21 loci contribute to the risk of esophageal squamous cell carcinomaJuan Shi, Fang Sun, Li Peng, et al.
American Journal of Cancer Research|November 14, 2019
Reversal of obesity-driven aggressiveness of endometrial cancer by metforminHui Guo, Weimin Kong, Lu Zhang, et al.
Eclinicalmedicine|January 30, 2023
A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study)Yuanyuan Zhao, Yunpeng Yang, Fangfang Gao, et al.
Radiology. Imaging Cancer|September 5, 2025
Using Machine Learning to Predict Advanced-Stage Progression of Intermediate-Stage Hepatocellular Carcinoma after Transarterial ChemoembolizationRan Wei, Zelong Liu, Lingjie Ju, et al.
Journal of Hematology & Oncology|September 23, 2016
NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivoLu Zhang, Jianjun Han, Amanda L Jackson, et al.
Breast Cancer Research : BCR|February 13, 2025
Clinical efficacy and therapy response prediction of neoadjuvant dalpiciclib plus letrozole in postmenopausal patients with HR+/HER2- stage II-III breast cancer (DARLING 01): a single-arm, open-label, exploratory studyLina Zhang, Yueping Liu, Chao Yang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 13, 2018
[Expert Consensus for Image-guided Radiofrequency Ablation of Pulmonary Tumors (2018 Version)]Baodong Liu, Xin Ye, Weijun Fan, et al.
Oncotarget|October 4, 2017
Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancerLi Sun, Yajie Yin, Leslie H Clark, et al.
Pancreas|August 4, 2021
Transcatheter Arterial Infusion Combined With Radioactive Particles in the Treatment of Advanced Body/Tail Pancreatic Cancer: A Retrospective Cohort StudyShilong Han, Chuanwu Cao, Yifeng Yuan, et al.
Frontiers in Oncology|July 19, 2021
Consensus of Minimally Invasive and Multidisciplinary Comprehensive Treatment for Hepatocellular Carcinoma - 2020 Guangzhou RecommendationsQi-Feng Chen, Wang Li, Simon Chun-Ho Yu, et al.
Pageof 9